Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer
Maturitas · 2026-01 · 204 · 108805
DOI: 10.1016/j.maturitas.2025.108805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maturitas, 2026-01. Verfasst von Famke C Wakkerman und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: f.c.wakkerman@lumc.nl. Hauptthemen laut MEDLINE: Patient Preference, Endometrial Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioNTech, Merck Sharp and Dohme K.K., KWF Kankerbestrijding.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: Adjuvant chemotherapy in the treatment of endometrial cancer can be difficult to tolerate for older women. This study examined age-related differences in patient preferences for chemotherapy in women with high-risk endometrial cancer. METHODS: We re-analyzed data from the cross-sectional patient preference study PRETEC-2 to determine the difference between three age groups in minimally desired survival benefit of chemotherapy. For this, patients with high-risk endometrial cancer treated with adjuvant pelvic radiotherapy with or without chemotherapy completed a treatment trade-off questionnaire. Patients also rated the importance they attributed to treatment duration and acute and late side-effects for their decision on chemotherapy, which we analyzed by age group. RESULTS: A total of 171 patients (23%
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: f.c.wakkerman@lumc.nl.
- Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Radiotherapy, Erasmus MC Cancer Center, Rotterdam, the Netherlands.
- Department of Radiation oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Institute Verbeeten, Tilburg, the Netherlands.
- Radiotherapiegroep, Arnhem, the Netherlands.
Förderung
- BioNTech
- Merck Sharp and Dohme K.K.
- KWF Kankerbestrijding
- Kurt Weill Foundation for Music
- European Research Council
Zitieren
APA
Wakkerman, F. C., Post, C. C. B., Mens, J. W. M., Jürgenliemk-Schulz, I. M., Koppe, F. L. A., Haverkort, M. A. D., Roeloffzen, E. M. A., Snyers, A., de Jong, M. A. A., Schaake, E. E., Beukema, J. C., Cnossen, J., Kiderlen, M., Lutgens, L. C. H. W., Nijman, H. W., de Kroon, C. D., Kroep, J. R., Pieterse, A. H., Creutzberg, C. L., & Horeweg, N. (2026). Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer. Maturitas, 204, 108805. https://doi.org/10.1016/j.maturitas.2025.108805
Vancouver
Wakkerman FC, Post CCB, Mens JWM, Jürgenliemk-Schulz IM, Koppe FLA, Haverkort MAD, et al. Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer. Maturitas. 2026;204:108805. doi:10.1016/j.maturitas.2025.108805
BibTeX
@article{Wakkerman2026,
author = {Wakkerman, Famke C and Post, Cathalijne C B and Mens, Jan Willem M and Jürgenliemk-Schulz, Ina M and Koppe, Friederike L A and Haverkort, Marie A D and Roeloffzen, Ellen M A and Snyers, An and de Jong, Marianne A A and Schaake, Eva E and Beukema, Jannet C and Cnossen, Jeltsje and Kiderlen, Mandy and Lutgens, Ludy C H W and Nijman, Hans W and de Kroon, Cornelis D and Kroep, Judith R and Pieterse, Arwen H and Creutzberg, Carien L and Horeweg, Nanda},
title = {Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer},
journal = {Maturitas},
year = {2026},
volume = {204},
pages = {108805},
doi = {10.1016/j.maturitas.2025.108805}
}
EUVIMED